FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/07/2026
Back to search
Official data from USPTO
BIOLEVATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOLEVATE
ST13
US500000079424297Class
9, 42
Filing
79424297
Registration
8122688
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
08/07/2026
Trademark type
Word
Nice classes
9, 42
Filing date
04/07/2025
Registration date
02/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2026
Last transaction
08/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
ZELLNER, SIERRA E
Law office
O50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BIOLEVATE
Representatives
R. Scott Keller Warner Norcross + Judd LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Recorded computer software programs featuring artificial intelligence software for analyzing and interpreting omics dataidentifying therapeutic targetsassisting in drug discoverysupporting medical writingdocument managementregulatory compliance analysis for use in the scientific and medical fields
Class 42
computer software design; computer software development; Rental of computer software for analyzing biological and chemical datasetsmodeling disease pathwayssupporting drug repurposing researchassisting in medical writingregulatory documentationcompliance review; computer system design; consultant services with respect to computer hardware design and development; Software as a service (SAAS) services featuring software for use in biomedical researchdrug discoverymolecular pathway analysismedical writingdocument managementregulatory complianceincluding identification of disease targetscandidate moleculesreview of scientific documentation; Providing advice regarding information technology specifically advice relating to computer software design; all the aforesaid services relating to artificial intelligence
Publications
History of USPTO decisions and trademark events.
21 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/07/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/16/2025
PUBO
PUBLISHED FOR OPPOSITION
12/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/17/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/17/2025
RFNT
REFUSAL PROCESSED BY IB
11/07/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/20/2025
RFRR
REFUSAL PROCESSED BY MPU
10/19/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/04/2025
CNRT
NON-FINAL ACTION WRITTEN
09/03/2025
DOCK
ASSIGNED TO EXAMINER
09/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/26/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/26/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/22/2025
Continuous trademark protection
Get notified about every new filing that threatens BIOLEVATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.